Literature DB >> 17062213

Right ventricle-to-pulmonary artery conduit versus Blalock-Taussig shunt: a hemodynamic comparison.

Nancy S Ghanayem1, Robert D B Jaquiss, Joseph R Cava, Peter C Frommelt, Kathleen A Mussatto, George M Hoffman, James S Tweddell.   

Abstract

BACKGROUND: A comprehensive assessment of 48 hour postoperative hemodynamics in neonates randomized to the right ventricle-to-pulmonary artery (RV-PA) conduit or modified Blalock-Taussig (BT) shunt for stage 1 palliation of hypoplastic left heart syndrome was performed to determine the potential benefits of the modified technique.
METHODS: Randomization to either RV-PA conduit or BT shunt was stratified by surgeon and the presence of aortic atresia. The designated procedure was performed by using hypothermic cardiopulmonary bypass with phenoxybenzamine, continuous cerebral perfusion, pH-stat blood gas management, and continuous postoperative venous oximetry. Differences between treatments were analyzed by time-series generalized least-squares regression, chi2 tests, two-way repeated measures analysis of variance, and the Levene variance ratio test for variability in parameters, as appropriate.
RESULTS: All patients underwent the procedure to which they were randomized. There were no differences in age, weight, deep hypothermic circulatory arrest, or cardiopulmonary bypass times between patients receiving the BT shunt (n = 8) or the RV-PA conduit (n = 9). There was one early and one late death in the RV-PA conduit group, and one interstage death in the BT shunt group. Other than diastolic blood pressure (39 mm Hg in BT shunt versus 46 mm Hg in RV-PA conduit, p < 0.001), there were no differences in the mean values of arterial saturation, venous oximetry, mean arterial blood pressure, pulmonary-to-systemic flow ratio (Qp/Qs), or any other physiologic or inotropic support variable between groups. The variability of physiologic values related to pulmonary blood flow was greater in the RV-PA group (Qp/Qs coefficient of variation, 0.91 versus 2.50, p < 0.001).
CONCLUSIONS: In this randomized prospective study, no hemodynamic benefits of the RV-PA modification for stage 1 palliation of hypoplastic left heart syndrome were found. Pulmonary blood flow was more variable, and the diastolic blood pressure was higher. These findings did not influence indicators of systemic oxygen delivery with our afterload reduction strategy.

Entities:  

Mesh:

Year:  2006        PMID: 17062213     DOI: 10.1016/j.athoracsur.2006.05.103

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  11 in total

1.  Right Ventricle-to-Pulmonary Artery Shunt in Pulmonary Atresia with a Ventricular Septal Defect: A Word of Caution.

Authors:  Kwang Ho Choi; Si Chan Sung; Hyungtae Kim; Hyoung Doo Lee; Gil Ho Ban; Geena Kim; Hoon Ko
Journal:  Pediatr Cardiol       Date:  2017-02-03       Impact factor: 1.655

2.  Fate of ventricular and valve performance following early bidirectional Glenn procedure after Norwood operation controlled for hypoplastic left heart syndome anatomic subtype.

Authors:  Anastasios C Polimenakos; John W Bokowski; Hani S Ghawi; Chawki F El-Zein; Michel N Ilbawi
Journal:  Pediatr Cardiol       Date:  2013-10-15       Impact factor: 1.655

Review 3.  Hypoplastic left heart syndrome: current perspectives.

Authors:  Christopher E Greenleaf; J Miguel Urencio; Jorge D Salazar; Ali Dodge-Khatami
Journal:  Transl Pediatr       Date:  2016-07

4.  Survival to Stage II with Ventricular Dysfunction: Secondary Analysis of the Single Ventricle Reconstruction Trial.

Authors:  Emilie Jean-St-Michel; James M Meza; Jonathon Maguire; John Coles; Brian W McCrindle
Journal:  Pediatr Cardiol       Date:  2018-03-08       Impact factor: 1.655

5.  Stage II palliation of hypoplastic left heart syndrome without cardiopulmonary bypass.

Authors:  Anthony Azakie; Natalie C Johnson; Petros V Anagnostopoulos; Sami M Akram; Patrick McQuillen; Anil Sapru
Journal:  J Thorac Cardiovasc Surg       Date:  2011-02       Impact factor: 5.209

6.  Outcome of Norwood operation for hypoplastic left heart syndrome.

Authors:  Vivek Rai; Tomasz Mroczek; Aleksander Szypulski; Agnieszka Pac; Marcin Gładki; Mirosława Dudyńska; Janusz Skalski
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2017-11-22

Review 7.  Consensus on timing of intervention for common congenital heart diseases: part II - cyanotic heart defects.

Authors:  P Syamasundar Rao
Journal:  Indian J Pediatr       Date:  2013-05-03       Impact factor: 1.967

8.  Interstage mortality after the Norwood procedure: Results of the multicenter Single Ventricle Reconstruction trial.

Authors:  Nancy S Ghanayem; Kerstin R Allen; Sarah Tabbutt; Andrew M Atz; Martha L Clabby; David S Cooper; Pirooz Eghtesady; Peter C Frommelt; Peter J Gruber; Kevin D Hill; Jonathan R Kaltman; Peter C Laussen; Alan B Lewis; Karen J Lurito; L LuAnn Minich; Richard G Ohye; Julie V Schonbeck; Steven M Schwartz; Rakesh K Singh; Caren S Goldberg
Journal:  J Thorac Cardiovasc Surg       Date:  2012-07-11       Impact factor: 5.209

9.  Family Function, Quality of Life, and Well-Being in Parents of Infants With Hypoplastic Left Heart Syndrome.

Authors:  Kathleen A Mussatto; Maria I Van Rompay; Felicia L Trachtenberg; Victoria Pemberton; Lisa Young-Borkowski; Karen Uzark; Danielle Hollenbeck-Pringle; Carolyn Dunbar-Masterson; Patricia Infinger; Patricia Walter; Kathleen Sawin
Journal:  J Fam Nurs       Date:  2021-02-04       Impact factor: 2.680

10.  Management of Congenital Heart Disease: State of the Art-Part II-Cyanotic Heart Defects.

Authors:  P Syamasundar Rao
Journal:  Children (Basel)       Date:  2019-04-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.